Abstract
Paul Newton and colleagues propose that clinical trial guidelines should include a requirement to assess and state the quality of the drugs and other medical products used
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Clinical Trials as Topic / standards*
-
Counterfeit Drugs
-
Equipment and Supplies / standards*
-
Guidelines as Topic*
-
Humans
-
Pharmaceutical Preparations / standards*
-
Placebos / standards*
Substances
-
Counterfeit Drugs
-
Pharmaceutical Preparations
-
Placebos